Pharmacovigilance fundamentals and goals contribute to protecting patient safety around the world. Ever-changing methodologies, tools, and ways of ensuring that key pharmacovigilance activities are at the highest standards, create efficiency and improve ways of working. Through clinical safety and pharmacovigilance programs and initiatives, DIA serves as a neutral platform for all pharmacovigilance stakeholders, a safe harbor to collaborate on shared challenges and opportunities for improvement and disseminate outcomes through DIA regional and global communities.
DIA Research: Advancing the Uses of AI in Biopharmaceutical Development
Phase 1: A Study on the Application and Use of Artificial Intelligence to Support Drug Development
Phase 2: Currently launching! Artificial Intelligence for Adverse Events Prediction
DIA is developing a use case that aims to help further the adoption and implementation of AI in adverse event identification and signal detection. If you are interested in becoming part of the study or learning more, please contact Science@DIAglobal.org.
Submit an Abstract
Submit an abstract for an existing or future event on any topic that advances the pharmaceutical, biotechnology, medical device, and related fields.
Content Highlights
Learn More
Certificate Program
DIA’s Safety and Pharmacovigilance Certificate Program is a comprehensive, competency-based program designed for individuals new to the field with one to three years of experience, or for those looking to broaden their expertise in this area.
eLearning Program
The Drug Safety eLearning Program provides the knowledge you need, from regulations and requirements through pre-market review and post-market monitoring.